stockrow
Friday 6 November 2026
Export ZTEKF’s income statement to Excel — free account
Zentek Ltd.
ZTEKF Healthcare Medical Instruments & Supplies
Zentek Ltd.’s revenue for fiscal 2026 (year ended March 2026) was $120,200.00, down 80.8% from fiscal 2025.
- Revenue
- −95.4%
- EPS
- 0.00%
- Free cash flow
- −254.6%
- Total debt
- +6.53%
Quarter to June 2026, against a year earlier
0.35
0.01
−2.78%
Follow ZTEKF
Alert me
Zentek Ltd. (ZTEKF) P/E ratio
Zentek Ltd. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| Jun 2025 | 0.0× | — |
| 13 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| STXS Stereotaxis Inc. compare | n/m |
| KRMD KORU Medical Systems, Inc. compare | n/m |
| POCI Precision Optics Corp. compare | n/m |
| MLSS Milestone Scientific, Inc. compare | n/m |
| HBIO Harvard Bioscience, Inc. compare | n/m |
| ZTEKF Zentek Ltd. | n/m |
| DXR Daxor Corporation compare | 4.0× |
| NEPH Nephros Inc. compare | 18.0× |
| DAVI Davion Healthcare PLC compare | — |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)